Vaccines Containing Canine Parvovirus Genetic Variants

Full-text?

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.

Abstract

PROBLEM TO BE SOLVED: To provide vaccines updated for preventing canine parvovirus (CPV) infections on the basis of heretofore unknown CPV variants and heretofore unrecognized findings of CPV variants, and diagnostics for detecting emerging CPV variants.SOLUTION: New vaccine formulations include whole attenuated CPV with single-stranded DNA having following characteristics: the codon encoding VP2 protein position 494 is TGC rather than TGT, and the codon encoding VP2 protein position 572 is GTC rather than GTA.


Claims

Information currently unavailable.

Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Dec 25, 2014
  • Application: Jul 10, 2014
    JP 2014142224 A
  • Priority: Feb 11, 2008
    US US 2761808 P
  • Priority: Jun 14, 2007
    US US 94394707 P

Download Citation


Sign in to the Lens

Feedback